Impact Of Omalizumab On Patient Reported Outcomes In Chronic Idiopathic Urticaria: Results From XTEND-CIU, A 48-Week, Randomized, Placebo-Controlled Study

Autor: Casale, Thomas B., Murphy, Thomas R., Holden, Michael, Le, Jamie A., Rajput, Yamina, Trzaskoma, Benjamin L., Bernstein, Jonathan A.
Zdroj: In The Journal of Allergy and Clinical Immunology February 2018 141(2) Supplement:AB405-AB405
Databáze: ScienceDirect
Externí odkaz: